Stock Taper 
Genworth Financial, founded in 1871 and based in Richmond, VA, offers mortgage, life, long-term care, and annuity insurance products globally through three segments: Enact, U.S. Life Insurance, and Runoff.
CareScout Care Assurance, offered by Genworth's subsidiary, is a sustainable long-term care insurance product reintroduced after 2016, providing financial protection for nursing, assisted living, and home health care expenses.
Genworth Financial announced the launch of its inaugural standalone long-term care (LTC) insurance product, 'Care Assurance,' through its CareScout platform. This marks a significant strategic pivot for the company, which has been navigating the challenges of the legacy LTC insurance market for years. The new, reportedly 'low-risk' product aims to offer a more sustainable and affordable solution for consumers.
After a multi-year hiatus, Genworth Financial strategically re-entered the long-term care insurance market in 2025 through its subsidiary, CareScout. This culminated in the October launch of 'CareScout Care Assurance,' a new standalone product designed with conservative pricing assumptions to avoid past profitability issues that plagued its legacy policies. This move is central to Genworth's strategy to capitalize on the growing senior care market and represents a significant pivot towards future growth.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
 CNO | $53.08 | COMPARE |
 HASI | $36.31 | COMPARE |
 UCB | $33.31 | COMPARE |
 INDB | $78.57 | COMPARE |
 CNS | $71.93 | COMPARE |
 BHF | $49.55 | COMPARE |
 BBAR | $13.20 | COMPARE |
 FG | $20.07 | COMPARE |
